24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
Fax: (361)578-5500

Basic InformationLatest News
Have Diabetes? Don't Lose Sight of Danger to Your EyesCommon Diabetes Meds Linked to Higher Odds for a Serious ComplicationAHA News: Controlling Diabetes Takes on Greater Urgency During COVID-19 PandemicStressful Days, Worse Blood Sugar Control for People With DiabetesAnimal Tests Point to Possible Path to Ultrafast InsulinSigns of Developing Adult Diabetes Seen as Early as Age 8: StudyDoes COVID-19 Trigger New Cases of Diabetes?Telehealth Programs Improve Blood Sugar for Rural Americans With DiabetesContinuous Glucose Monitors Help With Type 1 Diabetes at Any AgeCost of Type 1 Diabetes: $2,500 a Year With Insurance1 in 10 Hospitalized COVID-19 Patients With Diabetes Dies: StudyWhite House Announces Plan for Medicare Recipients to Get Insulin at $35 Per MonthLost Pregnancies, Diabetes May Be LinkedType 2 Diabetes Linked to Worse Mental Outcomes After StrokeSleep Apnea Tied to Raised Diabetes Risk in Black AmericansHeart Attacks, Strokes Are Declining Among People With DiabetesCould Your Contact Lenses Track, Treat Your Diabetes?AHA News: Managing Diabetes Risk in Hispanic, Asian CommunitiesObesity Is Biggest Type 2 Diabetes Risk FactorAHA News: Understanding the Risky Combination of Diabetes and the CoronavirusWhy Is Coronavirus a Bigger Worry for People With Diabetes?What People With Type 1 Diabetes Need to Know About COVID-19Family Ties Help Young Adults With Type 1 Diabetes FlourishPatch Pump Device Could Offer Cheaper Insulin DeliveryCan AI Predict Who Will Develop Diabetes?Blood Sugar Control May Aid Stroke Recovery in Diabetes PatientsBacteria May Be a Player in Diabetes Among Very ObeseNew Tool Helps Muslims With Diabetes Manage Blood Sugar During Ramadan FastWant to Help Keep Diabetes at Bay? Brush & FlossDiabetes Among U.S. Young, Especially Asians, Continues to ClimbDrug Duo Speeds Regeneration of Key Cells Lost in DiabetesMedicare Could Save Billions If Allowed to Negotiate Insulin PricesAt the Barbershop, a Trim -- and a Diabetes ScreeningCertain Diabetes Meds May Lower Gout Risk, TooBig Advances Made Against Diabetes in 2019CDC Study Breaks Down Diabetes Risk for Hispanic, Asian SubgroupsFDA Authorizes Marketing of Automated Insulin Dosing ControllerDo Processed Foods Up Your Type 2 Diabetes Risk?Changing Timing, Frequency of Meals May Help With Diabetes'Diabetes Burnout' Is Real, Here's How to CopeAs Diabetes Costs Soar, Many Turn to Black Market for HelpFDA Testing Levels of Carcinogen in Diabetes Drug MetforminMom-to-Be's Diabetes May Up Odds of Heart Disease in Her KidsPrediabetes Now Common Among Teens, Young AdultsHeart Attack at 44 Helped Her Realize Diabetes' DangersDiabetes Tougher on Women's HeartsDiabetes Technology Often Priced Out of ReachSupplements Don't Prevent Kidney Disease in Type 2 DiabeticsWhy Are Insulin Prices Still So High for U.S. Patients?Health Tip: Snacks for People With Diabetes
Related Topics

Medical Disorders

Continuous Glucose Monitors Help With Type 1 Diabetes at Any Age

HealthDay News
by By Serena Gordon
HealthDay Reporter
Updated: Jun 17th 2020

new article illustration

WEDNESDAY, June 17, 2020 (HealthDay News) -- Technology often makes life easier to manage, and new research confirms that's definitely the case for people with type 1 diabetes.

Continuous glucose monitors -- devices that approximate blood sugar levels every few minutes -- can help teens and young adults better manage their diabetes. They can also help older adults prevent dangerously low blood sugar levels (hypoglycemia), according to two new studies.

"The advent of continuous glucose monitoring (CGM) technology has revolutionized outpatient diabetes care in the past decade," wrote the authors of an accompanying editorial, Dr. Shivani Agarwal and Dr. Anne Cappola from Albert Einstein College of Medicine in New York City.

Continuous glucose monitors measure the amount of sugar (glucose) in interstitial fluid. That's fluid that surrounds the body's cells. The devices can track trends in glucose levels and provide alarms when sugar levels are rising or falling too quickly, or if they are out of an acceptable range.

This information allows people with diabetes to adjust their insulin dosing or to have a snack to prevent hypoglycemia when glucose levels are dropping quickly.

The device consists of a very thin sensor inserted under the skin to measure changes in glucose and a transmitter that attaches to the sensor. The transmitter is held in place on the skin with an adhesive patch. The transmitter sends information from the sensor wirelessly to a receiver, smartphone, tablet or certain insulin pumps.

One of the new studies looked specifically at how well CGMs could prevent hypoglycemia in older people with type 1 diabetes. People with type 1 diabetes produce little to no insulin, and must take insulin injections or receive insulin via an insulin pump to make up for that missing insulin.

But replacing just the right amount of insulin can be tricky. Too little insulin, and blood sugar levels may remain too high. Over time, that can lead to diabetes complications, such as vision problems, kidney disease, nerve conditions and heart disease. But too much insulin can cause hypoglycemia, which initially causes uncomfortable symptoms, but can lead to unconsciousness, seizures and even death if left untreated.

As people age, they may not feel the symptoms of early hypoglycemia, such as shakiness and a rapid heartbeat. Some develop a condition called hypoglycemia unawareness.

The study included more than 200 people over 60 years of age with type 1 diabetes. Half received a CGM to monitor their glucose levels, while the other half checked their blood sugar with a standard blood sugar meter (using a drop of blood pricked from the finger).

The people on CGM had lower rates of hypoglycemia. The CGM group had glucose levels lower than 70 milligrams per deciliter, the threshold for low blood sugar, 5% of the time before the study began (about 73 minutes per day), and for less than 3% of the time during the six-month study period (about 39 minutes a day).

Those checking their blood sugar with a standard meter had low glucose 4.7% of the time at the start of the study (68 minutes a day) and an average of 4.9% of the time during the study (70 minutes a day).

"There was a significant reduction in hypoglycemia for people randomized to CGM. There was also a reduction in unconsciousness, seizures and the need for medical attention. There was also an improvement in overall [blood sugar] control," said the study's lead author, Dr. Richard Pratley, medical director of the AdventHealth Diabetes Institute in Orlando, Fla.

"We learned that older individuals can use the technology to prevent hypoglycemia and improve their safety without compromising their [blood sugar] control. I think CGMs should be standard of care," he said.

Medicare began offering coverage of the devices in 2017.

The other study included more than 150 young people with type 1 diabetes, who were 14 to 24 years old. They were randomly assigned to CGM or a standard blood sugar meter. The researchers, led by Dr. Lori Laffel from Joslin Diabetes Center in Boston, wanted to learn if CGM could help young people better manage their diabetes.

The 26-week study showed a small, but statistically significant improvement in blood sugar control.

Dr. Gerald Bernstein is program coordinator at the Friedman Diabetes Institute at Lenox Hill Hospital in New York City. He said, "The use of CGM has been increasing but is nowhere close to its potential."

Bernstein added that both studies showed "a small statistical benefit of CGM," but he said that he expected the findings would have been more dramatic.

"My own feeling is that people on multidose insulin should use it along with a strong education program," he said.

However, Bernstein noted that there may sometimes be barriers to CGM use, such as insurance issues and out-of-pocket costs.

The studies and editorial were published June 16 in the Journal of the American Medical Association.

More information

Learn more about continuous glucose monitoring from the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.